References
- Seshia S S, Rjani K R, Boeckx R L, Chow P N. The neurological manifestations of chronic inhalation of leaded gasoline. Dev Med Child Neurol 1978; 20: 323–334
- Brady M. Heavy Metal: The social meaning of petrol sniffing in Australia. Aboriginal Studies Press, Canberra 1992; 27
- Goldings A S, Stewart R M. Organic lead encephalopathy: behavioral change and movement disorder following gasoline inhalation. J Clin Psychiatry 1982; 43: 70–72
- Kaelan C, Harper C, Vieira B I. Acute encephalopathy and death due to petrol sniffing: neuropathological findings. Aust N Z J Med 1986; 16: 804–807
- Fornazzari L. Clinical recognition and management of solvent abusers. Int Med Spec 1988; 9: 99–109
- Robinson R O. Tetraethyl lead poisoning from gasoline sniffing. JAMA 1978; 240: 1373–1374
- Boeckx R L, Postl B, Coodin F J. Gasoline sniffing and tetraethyl lead poisoning in children. Pediatrics 1977; 60: 140–145
- Kovanen J, Somer H, Schroeder P. Acute myopathy associated with gasoline sniffing. Neurology 1983; 33: 629–631
- Gabow P A, Kaehny W D, Kelleher S P. The spectrum of rhabdomyolysis. Medicine-Baltimore 1982; 61: 141–152
- Fischbach F. A Manual of Laboratory and Diagnostic Tests. JB Lippincott, Philadelphia 1992; 342–345
- Black H R, Quallich H, Gareleck C B. Racial differences in serum creatine kinase levels. Am J Med 1986; 81: 479–487
- Young D S. Effects of Drugs on Clinical Laboratory Tests. AACC, Washington 1990; 3: 121–122
- Knochel J P, Dotin L N, Hamburger R J. Heat stress, exercise, and muscle injury: effects on urate metabolism and renal function. Ann Intern Med 1974; 81: 321–328
- Royal Darwin Hospital. Protocol for treating petrol sniffers with lead encephalopathy. Royal Darwin Hospital, Darwin 1986
- Eastman Kodak. Creatine Kinase Test Methodology. Eastman Kodak, New York 1986
- Miller W G, Chinchilli V M, Gruemer H D, Nance W E. Sampling from a skewed population distribution as exemplified by estimation of the creatine kinase upper reference limit. Clin Chem 1984; 30: 18–23
- Anathasopoulos N, Chapple G. The determination of lead in blood by graphite furnace atomic absorption spectrophotometry. A.A. Applications. GBC Scientific, Victoria 1986; 2
- Gebski V, Leung O, McNeil D, Lunn A. SPIDA user manual (version 6). Macquarie University, Statistical laboratory, Sydney 1992
- National Health and Medical Research Council. Report of the 115th session: Lead in Australians. NHMRC, Canberra 1993
- Jensen A A. Metabolism and toxicokinetics. Biological Effects of Organolead Compounds, P Grandjean. CRC Press, Boca Raton 1984; 97–115
- Ramsey J D, Flanagan R J. The role of the laboratory in the investigation of solvent abuse. Hum Toxicol 1982; 1: 299–311
- Pedersen L M, Nygaard E, Nielsen O S, Saltin B. Solvent-induced occupational myopathy. J Occup Med 1980; 22: 603–606
- Reisin E, Teicher A, Jaffe R, Eliahou H E. Myoglobinuria and renal failure in toluene poisoning. Br J Ind Med 1975; 32: 163–164
- Swartz C M, Breen K J. Elevated serum CK in long abstinent cocaine abusers. Am J Drug Alcohol Abuse 1993; 19: 327–335
- Urbano-Marquez A, Estruch R, Navarro-Lopez F, Grau J M, Mont L, Rubin E. The effects of alcoholism on skeletal and cardiac muscle. N Engl J Med 1989; 320: 409–415
- Evans E B, Balster R L. CNS depressant effects of volatile organic solvents. Neurosci Biobehav Rev 1991; 15: 233–241